SGMT
Sagimet Biosciences Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.94
+0.18%0
Insider buys (3m)
5
Insider sells (3m)
-$4.5M
Net value (3m)
+60.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 17, 2026 | Kemble George · director | M-Exempt | 326,618 | $6.36 |
| Aug 17, 2026 | Kemble George · director | Sale | 350,987 | $10 |
| Aug 17, 2026 | Kemble George · director | M-Exempt | 24,369 | $6.36 |
| Aug 12, 2026 | Kemble George · director | M-Exempt | 9,751 | $6.36 |
| Aug 12, 2026 | Kemble George · director | Sale | 20,206 | $9.95 |
| Aug 12, 2026 | Kemble George · director | M-Exempt | 10,455 | $6.36 |
| Jul 22, 2026 | Rozek Elizabeth · officer: Chief Legal & Admin. Officer | Sale | 10,545 | $7.76 |
| Jul 22, 2026 | Kemble George · director | Sale | 18,844 | $7.46 |
| Jul 22, 2026 | Happel David · director, officer: President & CEO | Sale | 64,051 | $7.76 |
| Jun 15, 2026 | Phillips Anne M. · director | A-Award | 39,567 | $6.48 |
| Jun 15, 2026 | GRAMMER ELIZABETH A · director | A-Award | 39,567 | $6.48 |
| Jun 15, 2026 | Jarrett Jennifer · director | A-Award | 39,567 | $6.48 |
| Jun 15, 2026 | Hoelscher Paul W. · director | A-Award | 39,567 | $6.48 |
| Jun 15, 2026 | SEIDENBERG BETH C · director | A-Award | 39,567 | $6.48 |
| Jun 15, 2026 | Kemble George · director | A-Award | 39,567 | $6.48 |
| Jun 1, 2026 | Happel David · director, officer: President & CEO | A-Award | 300,000 | $7.27 |
| Jun 1, 2026 | Rozek Elizabeth · officer: Chief Legal & Admin. Officer | A-Award | 100,000 | $7.27 |
| Jun 1, 2026 | Grauer Andreas · officer: Chief Medical Officer | A-Award | 35,000 | $7.27 |
| Jun 1, 2026 | Chauche Thierry · officer: Chief Financial Officer | A-Award | 50,000 | $7.27 |
| May 14, 2026 | Grauer Andreas · officer: Chief Medical Officer | A-Award | 264,759 | $6.44 |
| Feb 20, 2026 | Happel David · director, officer: President & CEO | A-Award | 128,000 | $0.00 |
| Feb 20, 2026 | Rozek Elizabeth · officer: Chief Legal & Admin. Officer | A-Award | 44,000 | $0.00 |
| Feb 20, 2026 | Chauche Thierry · officer: Chief Financial Officer | A-Award | 88,000 | $5.38 |
| Feb 20, 2026 | Martins Eduardo Bruno · officer: Chief Medical Officer | A-Award | 88,000 | $5.38 |
| Feb 20, 2026 | Martins Eduardo Bruno · officer: Chief Medical Officer | A-Award | 44,000 | $0.00 |
| Feb 20, 2026 | Chauche Thierry · officer: Chief Financial Officer | A-Award | 44,000 | $0.00 |
| Feb 20, 2026 | Happel David · director, officer: President & CEO | A-Award | 256,000 | $5.38 |
| Feb 20, 2026 | Rozek Elizabeth · officer: Chief Legal & Admin. Officer | A-Award | 88,000 | $5.38 |
| Feb 12, 2026 | Chauche Thierry · officer: Chief Financial Officer | Sale | 1,312 | $5.36 |
| Feb 12, 2026 | Happel David · director, officer: President & CEO | Sale | 12,101 | $5.36 |
Institutional positioning
13F filings over the trailing two quarters
New 18Increased 32Reduced 22Sold out 87
| Filer | Action | Shares | Filed |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,098,919 | May 15, 2026 |
| WOODLINE PARTNERS LP | Unchanged | 1,000,943 | May 15, 2026 |
| MARSHALL WACE, LLP | Increased | 966,253 | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 952,996 | May 15, 2026 |
| AFFINITY ASSET ADVISORS, LLC | Reduced | 868,020 | May 14, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 862,303 | May 15, 2026 |
| BLACKROCK, INC. | Reduced | 799,943 | May 13, 2026 |
| HHLR ADVISORS, LTD. | Unchanged | 724,800 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 625,469 | May 14, 2026 |
| D. E. SHAW & CO., INC. | Reduced | 411,570 | May 15, 2026 |
| BLUE OWL CAPITAL HOLDINGS LP | Reduced | 333,877 | May 14, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 323,004 | May 15, 2026 |
| RAYMOND JAMES FINANCIAL INC | Increased | 317,550 | May 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 309,522 | May 15, 2026 |
| HUDSON BAY CAPITAL MANAGEMENT LP | Reduced | 303,223 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 17, 2026